1. Pantoprazole (PPZ) Inhibits RANKL-Induced Osteoclast Formation and Function In Vitro and Prevents Lipopolysaccharide- (LPS-) Induced Inflammatory Calvarial Bone Loss In Vivo
   Yu-Xi Li et al, 2020, Stem Cells International CrossRef
2. Proton Pump Inhibitors and the Risk of Early Aseptic Loosening in Hip and Knee Arthroplasty
   Iskandar Tamimi et al, 2022, Geriatric Orthopaedic Surgery & Rehabilitation CrossRef
3. Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases
   Gemma Di Pompo et al, 2022, Biomedicines CrossRef
4. Proton pump inhibitor use and risk of hip fracture in patients with type 2 diabetes
   Ya-Shuan Chou et al, 2020, Scientific Reports CrossRef
5. Biomechanical and biochemical evaluation of the effect of systemic application of omeprazole on the osseointegration of titanium implants
   Samet Tekin et al, 2021, International Journal of Implant Dentistry CrossRef
6. Влияние омепразола на остеобласты и остеокласты in vivo и в модели in vitro с использованием чешуи рыбы
   M.I. Zanaty et al, 2021, Биохимия CrossRef
7. Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength
   Md. Saddam Hussain et al, 2022, Journal of Basic and Clinical Physiology and Pharmacology CrossRef